Lyso-globotetraosylceramide (d18:1)

Lyso-globotetraosylceramide (d18:1) is a form of globotetraosylceramide (Gb4) without the fatty acyl group. Lyso-globotetraosylceramide (d18:1) can bind to the Shiga-like toxin pig verotoxin of edema disease (VTE) [1].

Product Specifications

CAS Number

[3077081-41-2]

Product Name Alternative

Lyso-globoside (d18:1)

UNSPSC

12352005

Target

Endogenous Metabolite

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Others

Smiles

O[C@@H]1[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@@H](O)[C@@H](O[C@H]3[C@@H](CO)O[C@@H](O[C@@H]4[C@@H](CO)O[C@@H](OC[C@H](N)[C@H](O)/C=C/CCCCCCCCCCCCC)[C@@H]([C@H]4O)O)[C@@H]([C@H]3O)O)O[C@@H]([C@@H]2O)CO)O[C@@H]([C@@H]1O)CO

Molecular Formula

C44H80N2O22

Molecular Weight

989.11

References & Citations

[1]DeGrandis, S., et al., (1989) . Globotetraosylceramide is recognized by the pig edema disease toxin. The Journal of biological chemistry, 264 (21), 12520–12525.|[2]Tribouillard-Tanvier, D., et al., (2008) . Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions. PloS one, 3 (4), e1981.